Lung cancer remains a leading cause of cancer related mortality worldwide. Despite
numerous advances in treatments over the past decade, non-small cell lung cancer …

The history of lung cancer epidemiology parallels the history of modern chronic disease
epidemiology. Although an excess of lung cancer was firstly observed among miners and …

Lung CT image segmentation is a necessary initial step for lung image analysis, it is a
prerequisite step to provide an accurate lung CT image analysis such as lung cancer …

Background Population-based cancer registration data in 2012 from all available cancer
registries were collected by the National Central Cancer Registry (NCCR). NCCR estimated …

Objective To explore the cancer patterns in areas with different urbanization rates (URR) in
China with data from 255 population-based cancer registries in 2013, collected by the …

Lung cancer is the deadliest cancer worldwide. Tissue biopsy is currently employed for the
diagnosis and molecular stratification of lung cancer. Liquid biopsy is a minimally invasive …

Anti-PD1/PD-L1 immunotherapy has emerged as a standard of care for stage III-IV non-
small cell lung cancer (NSCLC) over the past decade. Patient selection is usually based on …

BACKGROUND One immunotherapeutic agent for patients with advanced non‐small cell
lung carcinoma, pembrolizumab, has a companion immunohistochemistry (IHC)‐based …

Lung cancer is the second most common cancer and the leading cause of death in both men
and women in the world. Lung cancer is heterogeneous in nature and diagnosis is often at …

Protein-coding genes account for only a small part of the human genome; in fact, the vast
majority of transcripts are comprised of non-coding RNAs (ncRNAs) including long ncRNAs …